Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care. Cet article n’est pas disponible.Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care

Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care provides researchers with an extensive overview of recent advances in molecular biology impacting the development of targeted therapies. The book delivers insights into the pathobiological and pathogenetic mechanisms of various diseases, providing a detailed study of the latest personalized interventions to be implemented across such conditions. It covers a range of technologies, including RNA-sequencing, AI, Machine Learning, gene therapy, omics and nanotechnology, delving into their clinical applications across various diseases. The book also tackles targeted treatments of different disease types, including acute, chronic, infectious and noncommunicable diseases. Future perspectives are also covered, providing an in-depth study across molecular medicine, drug discovery and delivery, disease diagnosis and prevention, and therapeutic interventions, and acting as an invaluable interdisciplinary reference for researchers across the biomedical sciences.

Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health.

Dr Wilson’s career has spanned a number of decades and disciplines, from life as a junior chemist to academician at the University of Wales at Aberystwyth and Cardiff where he worked on diet and endocrinology. His early research emphasis was on cancer intervention using epidemiological evidence and related natural and synthetic products which has blossomed into works on phyto-oestrogens and flavonoids many of which form part of his several hundred publications.
Chronomedicine also formed a major part of his work on breast cancer detection using thermorhythmometric procedures.
He has 400-500 publications in biological sciences. In recognition of his contributions to science he has held senior positions in international and national organizations, memberships of many journal boards and is reviewer for many nutritional, statistical and cancer-related journals. He has been an invited global speaker at international events in USA, Asia and Europe and previously Australia and New Zealand.

Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.

Dr. Télessy is a retired associate professor at the University of Pécs (2008) and University of Szeged (2002). He is a specialist in pharmacology and clinical and hospital pharmacy. His main research activity has been in the fields of clinical nutrition and clinical pharmacy. He has published more than 90 papers, written two books (single author) and contributed 6 book chapters.
Dr. Télessy worked as pharmacist in public pharmacy for 20 years), in the pharmaceutical industry for 18 years and health authority for 5 years.
He is fellow of numerous societies and led the Public Pharmacy Advisory Board of the Minister of Healthcare for 13 years. He was Vice President of the Hungarian Society of Pharmaceutical Sciences and also played a role as lecturer in ESPEN International Expert Courses in Clinical Nutrition for Pharmacy.

Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025).